AstraZeneca’s Dapagliflozin gets extended indication approval from DCGI to treat heart failure in…
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.